Get 20% Free Customization In This Report

Buy this report from - $3456

Humanized Mouse Model Market by Type (Cell-based Humanized Mouse Model and Genetic Humanized Mouse Model), Application (Immunology & Infectious Diseases, Neuroscience, Oncology, Hematopoiesis, and Toxicology), and End User (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Diagnostics and Biotech	LI_182979	Pages: NA	Jul 2018 \| 741 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Humanized mouse is a mouse that possesses functioning human genes, cells, tissues, and/or organs in case of biological and medical research for human therapeutics. These mouse models are used to model the human immune system in scenarios of health and pathology.

Usage of mouse models for identification of immunodeficiency disorders, cancers, and other rare diseases, increase in R&D activities carried out by pharmaceutical & biotechnology companies; continuous support & initiatives from governments & private sectors for research on mouse models; and growth in adoption of modified medicine increase the demand for personalized mouse models.

However, stringent regulations and laws formulated for ethical use of animals and costly procedures for maintenance of animal housing restrain the growth of the global humanized mouse model market. Increased production of monoclonal antibodies and improvement of healthcare in developing nations are expected to provide growth opportunities for the market.

The humanized mouse model is segmented on the basis of type, application, end user, and region. Based on type, the market is bifurcated into cell-based humanized mouse model and genetic humanized mouse model. Cell-based humanized mouse models segment is further classified into CD34, PBMC, and BLT. Applications covered in the study include immunology & infectious diseases, neuroscience, oncology, hematopoiesis, toxicology, and others.

By end user, the market is divided into contract research organizations (CROs), pharmaceutical & biotechnology companies, and academic & research institutes. Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players operating in the global humanized mouse model market include The Jackson Laboratory, Taconic Biosciences, Inc., Harbour BioMed, HuMurine Technologies, Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience, Inc., ingenious targeting laboratory, Axenis S.A.S., TRANS GENIC, Inc., and genOway S. A.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Exhaustive analysis of the humanized mouse model market by type helps to understand the types of mouse that are currently being used along with the variants that are expected to gain prominence in the future.

Humanized Mouse Model Market Key Segments:

By Type

Cell-based Humanized Mouse Model
- CD34
- PBMC
- BLT
Genetic Humanized Mouse Model

By Application

Immunology & Infectious Diseases
Neuroscience
Oncology
Hematopoiesis
Toxicology
Other Applications

By End User

Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities

Chapter: 4 HUMANIZED MOUSE MODEL MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. GENETIC HUMANIZED MOUSE MODEL

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CELL BASED HUMANIZED MOUSE MODEL

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. CD34
4.3.5. PBMC
4.3.6. BLT

Chapter: 5 HUMANIZED MOUSE MODEL MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ONCOLOGY

5.2.1. Market size and forecast

5.3. IMMUNOLOGY AND INFECTIOUS DISEASE

5.3.1. Market size and forecast

5.4. NEUROSCIENCE

5.4.1. Market size and forecast

5.5. TOXICOLOGY

5.5.1. Market size and forecast

5.6. HAEMATOPOIESIS

5.6.1. Market size and forecast

5.7 OTHER

5.7.1. Market size and forecast

Chapter: 6 HUMANIZED MOUSE MODEL MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

6.2.1. Market size and forecast

6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.3.1. Market size and forecast

6.4. ACADEMIC & RESEARCH INSTITUTES

6.4.1. Market size and forecast

Chapter: 7 HUMANIZED MOUSE MODEL MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America humanized mouse model market, by type
7.2.5. North America humanized mouse model market, by application
7.2.6. North America humanized mouse model market, by end user

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe humanized mouse model market, by type
7.3.5. Europe humanized mouse model market, by application
7.3.6. Europe humanized mouse model market, by end user

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific humanized mouse model market, by type
7.4.5. Asia-Pacific humanized mouse model market, by application
7.4.6. Asia-Pacific humanized mouse model market, by end user

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

7.5.4. LAMEA humanized mouse model market, by type
7.5.5. LAMEA humanized mouse model market, by application
7.5.6. LAMEA humanized mouse model market, by end user

Chapter: 8 COMPANY PROFILES

8.1. THE JACKSON LABORATORY

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. TACONIC BIOSCIENCES INC.

8..2.1 Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. HARBOUR BIOMED

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. HUMURINE TECHNOLOGIES INC.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. VITALSTAR BIOTECHNOLOGY CO. LTD.

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. CROWN BIOSCIENCE INC.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. INGENIOUS TARGETING LABORATORY

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. AXENIS S.A.S.

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. TRANS GENIC, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. GENOWAY S.A.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

*Details on financial performance, strategic moves and developments may not be captured for unlisted companies.
* Please note this is a tentative TOC and may change with research proceedings.

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty